| Literature DB >> 35510164 |
Rita Georges Nohra1,2,3, Taghrid Chaaban1,4, Hala Sacre3, Pascale Salameh3,5,6,7, Zeina Aoun Bacha8, Beatrice Le Bon Chami9, Fadi Abou Rizk10, Paul Makhlouf11, Monique Rothan-Tondeur1,12.
Abstract
Purpose: The objective of this study was to investigate the feasibility and pretest the effectiveness of an educational and telemonitoring program in a sample of Lebanese COPD patients to inform the design of a randomized study. Patients andEntities:
Keywords: chronic obstructive pulmonary disease; knowledge; quality of life; skills; telehealth
Mesh:
Year: 2022 PMID: 35510164 PMCID: PMC9058009 DOI: 10.2147/COPD.S339592
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Sociodemographic Characteristics
| Socio-Demographic Characteristics of the Study Participants. | |
|---|---|
| Variables | Frequency (n), N=15 |
| Average ± Standard deviation | |
| Sex | Male (7) |
| Female (8) | |
| Age | 77 years ± 9.7 |
| Caregiver | Yes (11) |
| No (4) | |
| Stage of the disease | GOLD 2 (6) |
| GOLD 3 (7) | |
| GOLD 4 (2) | |
| Duration of illness | 9 years ± 4 |
| Health coverage | Without (9) |
| With (6) | |
Notes: N: population size.
Acceptability and Sociodemographic Variables
| This Program Seems an Acceptable Way to Address COPD Issues (Note/4) | ||
|---|---|---|
| Age | 0.05 | |
| ≤ 82 year | 3.62±0.51 | |
| >82 year | 3.14±0.377 | |
| Sex | 0.234 | |
| Male | 3.25 ±0.46 | |
| Female | 3.57±0.53 | |
| Stage of COPD | 0.368* | |
| Gold 2 | 3.33 ± 0.51 | |
| Gold 3 | 3.57 ± 0.53 | |
| Gold 4 | 3 | |
| Caregiver | 0.662 | |
| No | 3.5±0.57 | |
| Yes | 3.36±0.5 | |
| Duration of illness | 0.277 | |
| ≤ 10 years | 3.5±0.52 | |
| >10 years | 3.2±0.44 | |
| Health coverage | 0.693 | |
| Without | 3.44±0.52 | |
| With | 3.33±0.51 | |
Notes: P value calculated with t test, *P value calculated with ANOVA test.
Abbreviations: Note/4, the total score for acceptability equal 4.
Acceptability Score Relative to Each Session
| I Find This Education Session Acceptable to Meet My Original Goal (Note/4) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | P11 | P12 | P13 | P14 | P15 | Average | |
| S1 | 4 | 3 | 3 | 4 | 3 | 4 | 4 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 3.53 ± 0.49 |
| S2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3.06 ± 0.24 |
| S3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 ± 0 |
| S4 | 4 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3.8 ± 0.4 |
| S5 | 4 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 3.66 ± 0.47 |
| S6 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 3.33 ± 0.47 |
Abbreviations: P, patients; S, session; Note/4, the total score for this question equal 4.
CAT, CCQ and Sociodemographic Variables
| Variable | Score CAT | Score CCQ | ||
|---|---|---|---|---|
| No change/ worsening (Patient/15) | Improvement (Patient/15) | No change/ worsening (Patient/15) | Improvement (Patient/15) | |
| Age | ||||
| ≤ 82 years | 4 | 4 | 2 | 6 |
| > 82 years | 5 | 2 | 5 | 2 |
| P value | 0.6 | 0.13 | ||
| Sex | ||||
| Male | 5 | 3 | 5 | 3 |
| Female | 4 | 3 | 2 | 5 |
| P value | 1 | 0.31 | ||
| Stage of COPD | ||||
| GOLD 2 | 4 | 2 | 5 | 1 |
| GOLD 3 | 4 | 3 | 4 | 3 |
| GOLD 4 | 1 | 1 | 1 | 1 |
| P value | 0.897 | 0.526 | ||
| Caregiver | ||||
| No | 3 | 1 | 2 | 2 |
| Yes | 6 | 5 | 5 | 6 |
| P value | 0.6 | 1 | ||
| Duration of illness | ||||
| ≤ 10 years | 6 | 4 | 3 | 7 |
| >10 years | 3 | 2 | 4 | 1 |
| P value | 0.713 | 1 | ||
| Health coverage | ||||
| Without | 6 | 3 | 5 | 4 |
| With | 3 | 3 | 2 | 4 |
| P value | 0.62 | 0.6 | ||
Figure 1SpO2 variation for Patient 2 throughout the program.
Figure 2SpO2 variation for Patient 3 throughout the program.
Figure 3SpO2 variation for Patient 11 throughout the program.
Figure 4SpO2 variation for Patient 12 throughout the program.
Figure 5SpO2 variation for Patient 13 throughout the program.
Figure 6SpO2 variation for Patient 14 throughout the program.
Figure 7SpO2 variation for Patient 15 throughout the program.
Assessment of Participant’s Knowledge
| S1 (Note/5) | S2 (Note/5) | S3 (Note/5) | S4 (Note/5) | S5 (Note/5) | S6 (Note/5) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning | End | Beginning | End | Beginning | End | Beginning | End | Beginning | End | Beginning | End | |
| P1 | 2 | 4 | 5 | 5 | 2 | 4 | 2 | 4 | 2 | 3 | 2 | 4 |
| P2 | 4 | 5 | 5 | 5 | 4 | 5 | 3 | 4 | 4 | 5 | 3 | 4 |
| P3 | 3 | 3 | 3 | 5 | 3 | 4 | 4 | 5 | 3 | 5 | 1 | 3 |
| P4 | 4 | 5 | 5 | 5 | 3 | 4 | 5 | 5 | 3 | 5 | 4 | 5 |
| P5 | 4 | 5 | 1 | 4 | 3 | 4 | 1 | 3 | 5 | 5 | 2 | 3 |
| P6 | 5 | 5 | 5 | 5 | 4 | 5 | 1 | 4 | 2 | 4 | 4 | 5 |
| P7 | 2 | 5 | 5 | 5 | 2 | 4 | 5 | 5 | 1 | 3 | 3 | 4 |
| P8 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| P9 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 2 | 3 | 2 | 3 |
| P10 | 5 | 5 | 5 | 5 | 5 | 5 | 2 | 4 | 5 | 5 | 5 | 5 |
| P11 | 4 | 5 | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 5 |
| P12 | 3 | 4 | 3 | 5 | 4 | 5 | 3 | 5 | 3 | 5 | 4 | 5 |
| P13 | 3 | 5 | 5 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 3 | 4 |
| P14 | 3 | 5 | 3 | 5 | 3 | 5 | 2 | 4 | 2 | 4 | 3 | 3 |
| P15 | 3 | 4 | 4 | 5 | 5 | 5 | 3 | 4 | 4 | 5 | 4 | 5 |
| P value | 0.001 | 0.016 | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
Abbreviations: P, patient; S, session.